WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark C. SchneyerCFO;EVP2026-08-065,000$29.00
$145.00kSell
Mark C. SchneyerCFO;EVP2026-08-069,292$29.34
$272.60kSell
Mark C. SchneyerCFO;EVP2026-08-0614,292$17.84
$254.97kBuy
Mark C. SchneyerCFO;EVP2026-08-055,849$17.84
$104.35kBuy
Mark C. SchneyerCFO;EVP2026-08-055,849$29.00
$169.64kSell
Elizabeth Hz ThompsonEVP;Head2026-07-3050$26.17
$1.31kSell
Elizabeth Hz ThompsonEVP;Head2026-07-3016,508$26.13
$431.35kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-06-2611,421$26.09
$297.92kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-05-265,401$21.18
$114.39kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2026-05-043,506$21.79
$76.40kSell

1 of 3

ACAD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP22.92%39,487,463$1.15BInsider
Baker Brothers Life Sciences LP8.26%14,229,612$414.22MInsider
Oxford Bioscience Partners IV LP1.83%3,160,238$91.99MInsider
Nomura International PLC1.28%2,199,010$64.01MInsider
Osch Martien Van0.68%1,168,892$34.03MInsider
667 LP0.61%1,045,475$30.43MInsider
14159 LP0.46%799,265$23.27MInsider
Carl L. Gordon0.36%621,606$18.09MInsider
Felix Baker0.26%440,802$12.83MInsider
Mark R. Brann0.21%370,349$10.78MInsider

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD0.10%37.54%Net SellingNet Selling
PBLS0.08%6.36%Net BuyingNet Buying
DYN0.10%20.12%Net SellingNet Selling
EWTX0.11%14.46%Net SellingNet Selling
DFTX0.09%34.42%Net SellingNet Selling
View Top Biotech Stocks

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 0.10% institutional shareholders, 37.54% Acadia Pharmaceuticals insiders, and 62.36% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.49M shares representing 22.92% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $1.15B.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.